Westerband A, Crouse D, Richter L C, Aguirre M L, Wixon C C, James D C, Mills J L, Hunter G C, Heimark R L
Section of Vascular Surgery, and the Department of Pathology, University of Arizona Health Sciences Center and Southern Arizona VA Health Care System, Tucson, AZ, USA.
J Vasc Surg. 2001 Mar;33(3):561-9. doi: 10.1067/mva.2001.112230.
The events preceding myointimal thickening in vein grafts after vascular reconstructions are not well characterized. Indeed, the injury response associated with vein graft arterialization may be different than that observed in the balloon angioplasty model. Therefore, we used a rat model to study the early cellular response after arterialization of vein grafts.
Epigastric veins were placed as femoral artery interposition grafts in 37 male Lewis rats (weight range, 350-400 g). Vein grafts and contralateral epigastric veins were harvested at different time points (6 hours, 1 day, 2 days, 3 days, 7 days, 14 days, 21 days, 30 days, and 70 days). Tissue specimens were processed for histology and immunohistochemistry with antibodies for the proliferating cell nuclear antigen (PCNA) and for different cell types. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay was used as a means of determining the presence of apoptosis. Electron microscopy was used as means of assessing the integrity of the endothelial cell surface (SEM) and confirming the presence of apoptosis (TEM). Specimens were also snap frozen in liquid nitrogen for RNA isolation and molecular analysis.
At 1 day, endothelial denudation with platelet deposition on the surface was shown by means of SEM. Both apoptosis and necrosis of smooth muscle cells (SMCs) were present in the media, along with monocyte infiltration. Cellular proliferation and apoptosis were most intense within the first week of implantation. PCNA staining was first seen in the adventitial fibroblasts and microvessels, then in the medial SMCs at 3 days. With reverse transcriptase polymerase chain reaction, upregulation of vascular endothelial growth factor (VEGF) messenger RNA (mRNA) was noted at 1 day. Myointimal thickening progressively developed, with no apparent diminution of the luminal area as long as 70 days after implantation. By means of the analysis of the transforming growth factor beta1, mRNA showed expression during intimal thickening and accumulation of extracellular matrix. Reendothelialization was complete at 30 days.
These observations indicate that the cellular composition in our vein graft model is similar to human stenotic explants. Endothelial denudation is observed in rat vein grafts with complete regeneration by 30 days. VEGF mRNA is upregulated at 1 day, followed by proliferation of microvessel endothelial cells in the adventitia. Cellular proliferation and apoptosis are minimal after 21 days, with progressive intimal thickening likely to be the result of matrix accumulation.
血管重建术后静脉移植物肌内膜增厚之前的事件尚未得到充分描述。实际上,与静脉移植物动脉化相关的损伤反应可能与球囊血管成形术模型中观察到的不同。因此,我们使用大鼠模型来研究静脉移植物动脉化后的早期细胞反应。
将腹壁静脉作为股动脉间置移植物植入37只雄性Lewis大鼠(体重范围350 - 400克)体内。在不同时间点(6小时、1天、2天、3天、7天、14天、21天、30天和70天)采集静脉移植物和对侧腹壁静脉。组织标本进行组织学处理,并使用增殖细胞核抗原(PCNA)抗体和针对不同细胞类型的抗体进行免疫组织化学分析。末端脱氧核苷酸转移酶介导的dUTP - 生物素缺口末端标记(TUNEL)法用于确定凋亡的存在。电子显微镜用于评估内皮细胞表面的完整性(扫描电子显微镜)并确认凋亡的存在(透射电子显微镜)。标本还在液氮中速冻以进行RNA分离和分子分析。
扫描电子显微镜显示,术后1天可见内皮剥脱,表面有血小板沉积。中膜存在平滑肌细胞(SMC)的凋亡和坏死,伴有单核细胞浸润。细胞增殖和凋亡在植入后的第一周最为强烈。PCNA染色首先见于外膜成纤维细胞和微血管,然后在术后3天见于中膜SMC。通过逆转录聚合酶链反应,术后1天发现血管内皮生长因子(VEGF)信使核糖核酸(mRNA)上调。肌内膜增厚逐渐发展,直至植入后70天管腔面积无明显减小。通过对转化生长因子β1的分析,mRNA在内膜增厚和细胞外基质积聚过程中呈表达状态。术后30天内皮再形成完成。
这些观察结果表明,我们的静脉移植物模型中的细胞组成与人类狭窄标本相似。大鼠静脉移植物中观察到内皮剥脱,30天可完全再生。VEGF mRNA在术后1天上调,随后外膜微血管内皮细胞增殖。术后21天后细胞增殖和凋亡极少,内膜逐渐增厚可能是基质积聚的结果。